abstract |
The present invention relates to compounds of formula (I) or (II) below, which are hepatitis C virus NS5B polymerase inhibitors. The invention also relates to compositions and methods for the treatment of HCV infection and for the inhibition of HCV replication: Formula I Formula II Where R 1 , R 2 , B and V are as defined herein. |